Cyclosporine-associated mutism in liver transplant patients.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8559388.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Four liver transplant recipients treated with cyclosporine developed a reversible neurologic syndrome characterized by a speech disorder leading to mutism. This complication, previously reported in a few liver transplant recipients treated with the immunosuppressive drug FK506, had not been described with cyclosporine. Recognition of this syndrome should prompt withdrawal of the drug and avoidance of unnecessary diagnostic procedures.
Medical subject headings
- Cyclosporine
- Liver Transplantation
- Mutism